Official Publications PHAXIAM Therapeutics S.A.

Equities

End-of-day quote Euronext Paris Other stock markets 06:00:00 2024-06-06 pm EDT			5-day change	1st Jan Change
2.865 ^EUR	-0.52%		-4.34%	-37.72%

Apr. 15	Phaxiam initiates trial in infective endocarditis	CF
Apr. 15	PHAXIAM Therapeutics Announces Enrolment of First Patient in the Phase 1 Study for the Treatment of Endocarditis Infections Caused by Staphylococcus Aureus	CI

Threshold crossings	22-11-21	CO
3rd quarter turnover	22-11-20	CO
3rd quarter turnover	22-11-20	CO
Monthly statement on voting rights	22-10-30	CO
Monthly statement on voting rights	22-10-30	CO
Monthly statement on voting rights	22-09-29	CO
Monthly statement on voting rights	22-09-29	CO
Slide show half-year results	22-09-12	CO
Half-year report	22-09-11	CO
SEC Filing 6K-2	22-09-11	CO
1st-half-year results	22-09-11	CO
1st-half-year results	22-09-11	CO
Monthly statement on voting rights	22-08-30	CO
Monthly statement on voting rights	22-08-30	CO
Monthly statement on voting rights	22-07-30	CO
Monthly statement on voting rights	22-07-30	CO
Monthly statement on voting rights	22-06-29	CO
Monthly statement on voting rights	22-06-29	CO
Monthly statement on voting rights	22-05-30	CO
Monthly statement on voting rights	22-05-30	CO
Monthly statement on voting rights	22-05-17	CO
1st quarter results	22-05-11	CO
1st quarter results	22-05-11	CO
Monthly statement on voting rights	22-04-29	CO
Monthly statement on voting rights	22-04-29	CO